TGF-β-treated peripheral blood monocyte-derived macrophages (MDMs) have been shown to have a two times reduced ability to kill P. aeruginosa. Furthermore, a reduced antimicrobial ability of MDMs was observed when co-cultured with primary CF AECs in comparison with non-CF controls. The gene discussed is TGFB1; the disease is cystic fibrosis.